FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
FDA General

DoJ Lawyer Tapped as FDA Chief Counsel

HHS appoints Justice Department attorney Hilary Perkins to serve as FDA chief counsel.

Medical Devices

J&Js Monarch Quest Bronchoscopy Navigation Cleared

FDA clears a Johnson & Johnson MedTech 510(k) for its Monarch Quest, an advanced navigation technology for robotically assisted bronchoscopy.

latest-news-card-1
Federal Register

Comments Reopened on Good Clinical Practice Guide

Federal Register notice: FDA reopens the comment period for its draft guidance entitled E6(R3) Good Clinical Practice: Annex 2.

Biologics

Priority Review for DMD Cardiomyopathy BLA

FDA accepts for priority review an NS Pharma BLA for deramiocel, an investigational cell therapy for Duchenne muscular dystrophy cardiomyopathy.

Zenrelia Promotions False and Misleading: FDA

FDA warns Elanco Animal Health that promotional materials for its Zenrelia are misbranded due to false and misleading representations about the canine...

Biologics

FDA Safety Alert on Immune Globulin Products

An FDA safety alert says several manufacturers have recalled several lots of immune globulin intravenous and subcutaneous products due to a higher rat...

latest-news-card-1
Human Drugs

CGMP Deviations at Shree Jaya Unit

FDA warns Indias Shree Jaya Laboratories about CGMP deviations in its production of active pharmaceutical ingredients at a facility in Yadadri Bhuvana...

EIRS/483s

Linghai ZhanWang Records Show CGMP Violations

FDA warns Chinas Linghai ZhanWang Biotechnology Co. about CGMP violations in its manufacturing of over-the-counter drugs.

latest-news-card-1
Human Drugs

Positive Data on Pfizer/Arvinas Breast Cancer Study

Pfizer and Arvinas announce positive topline results from a clinical trial evaluating vepdegestrant monotherapy versus fulvestrant in certain adults w...

latest-news-card-1
Human Drugs

FDA Rejects All Mid-Link Technology Data

FDA tells Chinas Mid-Link Technology Testing Co. it is rejecting all data from all studies conducted by the company until it provides a substantive re...